Christian Meierhofer1, Andreas Kühn2, Jan Müller2, Nerejda Shehu2, Alfred Hager2, Stefan Martinoff3, Heiko Stern2, Peter Ewert2, Manfred Vogt2,4. 1. Pediatric Cardiology and Congenital Heart Disease, Deutsches Herzzentrum München, Technical University of Munich, Lazarettstrasse 36, 80636, Munich, Germany. meierhofer@dhm.mhn.de. 2. Pediatric Cardiology and Congenital Heart Disease, Deutsches Herzzentrum München, Technical University of Munich, Lazarettstrasse 36, 80636, Munich, Germany. 3. Radiology, Deutsches Herzzentrum München, Technical University of Munich, Munich, Germany. 4. Kinderherzpraxis München, Munich, Germany.
Abstract
BACKGROUND: Exercise capacity is a well-defined marker of outcome in congenital heart disease. We analyzed seventeen cardiovascular magnetic resonance (CMR) derived parameters and their correlation to exercise capacity in patients with Ebstein's anomaly (EA). METHODS: Fifty-four surgery free patients, age 5 to 69 years (median 30 years) prospectively underwent CMR examination and cardiopulmonary exercise testing (CPET). The following volume/flow parameters were compared with peak oxygen uptake as the percentage of normal (peakVO2%) using univariate and multivariate analysis: right and left ventricular ejection fraction (RVEF and LVEF), the indexed end-diastolic and end-systolic volumes (RVEDVi, RVESVi, LVEDVi, and LVESVi), the indexed stroke volumes (RVSVi and LVSVi), the total normalized right and left heart volumes; the total right to left heart volume ratio (R/L-ratio). The indexed antegrade flow (ante), indexed net flow (net) as well as cardiac index (CI) in the aorta (Ao) and pulmonary artery (PA) were used. RESULTS: RVEF (R2 0.2788), indexed flow PA net (R2 0.2330), and PA ante (R2 0.1912) showed the best correlation with peakVO2% (all p < 0.001) in the univariate model. Further significant correlation could also be demonstrated with CI-PA, LVEF, LVSVi, Aorta net, RVESVi, and Aorta ante. Multivariate analysis for RVEF and indexed net flow PA revealed a R2 of 0.4350. CONCLUSION: Functional CMR parameters as RVEF and LVEF and flow data of cardiac forward flow correlate to peakVO2%. Evaluation of the indexed net flow in the pulmonary artery and the overall function of the right ventricle best predicts the maximal exercise capacity in patients with EA.
BACKGROUND: Exercise capacity is a well-defined marker of outcome in congenital heart disease. We analyzed seventeen cardiovascular magnetic resonance (CMR) derived parameters and their correlation to exercise capacity in patients with Ebstein's anomaly (EA). METHODS: Fifty-four surgery free patients, age 5 to 69 years (median 30 years) prospectively underwent CMR examination and cardiopulmonary exercise testing (CPET). The following volume/flow parameters were compared with peak oxygen uptake as the percentage of normal (peakVO2%) using univariate and multivariate analysis: right and left ventricular ejection fraction (RVEF and LVEF), the indexed end-diastolic and end-systolic volumes (RVEDVi, RVESVi, LVEDVi, and LVESVi), the indexed stroke volumes (RVSVi and LVSVi), the total normalized right and left heart volumes; the total right to left heart volume ratio (R/L-ratio). The indexed antegrade flow (ante), indexed net flow (net) as well as cardiac index (CI) in the aorta (Ao) and pulmonary artery (PA) were used. RESULTS: RVEF (R2 0.2788), indexed flow PA net (R2 0.2330), and PA ante (R2 0.1912) showed the best correlation with peakVO2% (all p < 0.001) in the univariate model. Further significant correlation could also be demonstrated with CI-PA, LVEF, LVSVi, Aorta net, RVESVi, and Aorta ante. Multivariate analysis for RVEF and indexed net flow PA revealed a R2 of 0.4350. CONCLUSION: Functional CMR parameters as RVEF and LVEF and flow data of cardiac forward flow correlate to peakVO2%. Evaluation of the indexed net flow in the pulmonary artery and the overall function of the right ventricle best predicts the maximal exercise capacity in patients with EA.
Authors: Sohrab Fratz; Christine Janello; Dorothea Müller; Manuel Seligmann; Christian Meierhofer; Tibor Schuster; Christian Schreiber; Stefan Martinoff; John Hess; Andreas Kühn; Manfred Vogt; Heiko Stern Journal: Int J Cardiol Date: 2012-01-24 Impact factor: 4.164
Authors: Christine H Attenhofer Jost; Heidi M Connolly; Joseph A Dearani; William D Edwards; Gordon K Danielson Journal: Circulation Date: 2007-01-16 Impact factor: 29.690
Authors: Jelena Radojevic; Ryo Inuzuka; Rafael Alonso-Gonzalez; Francesco Borgia; Georgios Giannakoulas; Matina Prapa; Emmanouil Liodakis; Wei Li; Lorna Swan; Gerhard Paul Diller; Konstantinos Dimopoulos; Michael A Gatzoulis Journal: Int J Cardiol Date: 2011-06-28 Impact factor: 4.164
Authors: Andreas Kühn; Gabriella De Pasquale Meyer; Jan Müller; Kurt Petzuch; Sohrab Fratz; Christoph Röhlig; Alfred Hager; Christian Schreiber; John Hess; Manfred Vogt Journal: Int J Cardiol Date: 2011-12-26 Impact factor: 4.164
Authors: Daniel Tobler; Sergey Yalonetsky; Andrew M Crean; John T Granton; Luke Burchill; Candice K Silversides; Rachel M Wald Journal: Int J Cardiol Date: 2011-08-27 Impact factor: 4.164
Authors: Philip J Kilner; Tal Geva; Harald Kaemmerer; Pedro T Trindade; Juerg Schwitter; Gary D Webb Journal: Eur Heart J Date: 2010-01-11 Impact factor: 29.983